---
title: BT-142 Orthotopic Model - TD2 Precision Oncology
description: BT-142 is a glioblastoma multiforme cell line widely used for studying brain cancer and testing therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/bt-142.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# BT-142 Orthotopic Model
**Synonyms:** BT142
BT-142 is a cell line derived from human glioblastoma multiforme (GBM), a highly aggressive brain cancer. It serves as a valuable tool for studying GBM pathogenesis and evaluating therapeutic approaches. BT-142 exhibits key molecular features and genetic alterations observed in GBM patients, making it a representative model for preclinical investigations. Its in vitro and in vivo behavior closely mimics the characteristics of GBM, including invasive growth, angiogenesis, and resistance to conventional treatments. Researchers utilize BT-142 to gain insights into GBM biology and to develop novel treatment strategies.
## Model Details
**Cancer Type:** Brain Cancer
**Model Name:** BT-142
**Mouse Strain:** Nu/Nu
**Treatment Data Available:** N/A
## BT-142 Survival
Survival of BT-142 after orthotopic intracranial injection in Nu/Nu mice (n=5)
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)